Sherwin Navaz
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Atherosclerosis and Cardiovascular Diseases 1
- Inflammation biomarkers and pathways 1
-
- S100 Proteins and Annexins 2
- Co-authors
- Yu Zuo (5 shared papers)Jason S. Knight (5 shared papers)Alyssa Harbaugh (3 shared papers)Yogendra Kanthi (3 shared papers)Srilakshmi Yalavarthi (2 shared papers)Kelsey Gockman (2 shared papers)Claire K. Hoy (2 shared papers)Melanie Zuo (2 shared papers)
- Journals
- JAMA Network Open (1 paper)Arthritis & Rheumatology (1 paper)JCI Insight (1 paper)JAMA Cardiology (1 paper)Diagnostics (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Sherwin Navaz
5 papers receiving 139 citations
Peers
Comparison fields: 5 of 43
- Infectious Diseases 62
- Neurology 39
- Immunology 51
- Critical Care and Intensive Care Medicine 10
- Rheumatology 25
Countries citing papers authored by Sherwin Navaz
This map shows the geographic impact of Sherwin Navaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherwin Navaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherwin Navaz more than expected).
Fields of papers citing papers by Sherwin Navaz
This network shows the impact of papers produced by Sherwin Navaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherwin Navaz. The network helps show where Sherwin Navaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherwin Navaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 58 | |
| 2 | 2022 | 55 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 11 | |
| 5 | 2025 | 1 |
About Sherwin Navaz
Sherwin Navaz is a scholar working on Immunology, Molecular Biology, Infectious Diseases, Nephrology and Critical Care and Intensive Care Medicine, having authored 5 papers that have together received 141 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), COVID-19 Clinical Research Studies (2 papers), S100 Proteins and Annexins (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Renal Diseases and Glomerulopathies (1 paper), Systemic Lupus Erythematosus Research (1 paper), Inflammation biomarkers and pathways (1 paper) and Retinal and Optic Conditions (1 paper). The work is most often cited by research in Infectious Diseases (62 citations), Neurology (39 citations), Immunology (51 citations), Critical Care and Intensive Care Medicine (10 citations) and Rheumatology (25 citations). Sherwin Navaz has collaborated with scholars based in United States and China. Frequent co-authors include Yu Zuo, Jason S. Knight, Alyssa Harbaugh, Yogendra Kanthi, Srilakshmi Yalavarthi, Kelsey Gockman, Claire K. Hoy, Melanie Zuo, Jacqueline A. Madison and Hui Shi. Their work appears in journals such as JAMA Network Open, Arthritis & Rheumatology, JCI Insight, JAMA Cardiology and Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.